Literature DB >> 12958066

Ephrin receptor, EphB4, regulates ES cell differentiation of primitive mammalian hemangioblasts, blood, cardiomyocytes, and blood vessels.

Zhengyu Wang1, Kenneth Cohen, Ying Shao, Pamela Mole, David Dombkowski, David T Scadden.   

Abstract

Differentiation of pluripotent embryonic stem (ES) cells is associated with expression of fate-specifying gene products. Coordinated development, however, must involve modifying factors that enable differentiation and growth to adjust in response to local microenvironmental determinants. We report here that the ephrin receptor, EphB4, known to be spatially restricted in expression and critical for organized vessel formation, modifies the rate and magnitude of ES cells acquiring genotypic and phenotypic characteristics of mesodermal tissues. Hemangioblast, blood cell, cardiomyocyte, and vascular differentiation was impaired in EphB4-/- ES cells in conjunction with decreased expression of mesoderm-associated, but not neuroectoderm-associated, genes. Therefore, EphB4 modulates the response to mesoderm induction signals. These data add differentiation kinetics to the known effects of ephrin receptors on mammalian cell migration and adhesion. We propose that modifying sensitivity to differentiation cues is a further means for ephrin receptors to contribute to tissue patterning and organization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958066     DOI: 10.1182/blood-2003-04-1063

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  Endothelial cells regulate cardiomyocyte development from embryonic stem cells.

Authors:  Kang Chen; Hao Bai; Melanie Arzigian; Yong-Xing Gao; Jing Bao; Wen-Shu Wu; Wei-Feng Shen; Liqun Wu; Zack Z Wang
Journal:  J Cell Biochem       Date:  2010-09-01       Impact factor: 4.429

Review 2.  Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis.

Authors:  Gregor Prindull
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

3.  Multivalent biomaterial platform to control the distinct arterial venous differentiation of pluripotent stem cells.

Authors:  Taylor B Dorsey; Diana Kim; Alexander Grath; Daylon James; Guohao Dai
Journal:  Biomaterials       Date:  2018-09-03       Impact factor: 12.479

4.  Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells.

Authors:  Elisa Ciraci; Silvia Della Bella; Ombretta Salvucci; Cristina Rofani; Marta Segarra; Caterina Bason; Agnese Molinari; Dragan Maric; Giovanna Tosato; Anna C Berardi
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

Review 5.  Intercellular cross-talk among bone cells: new factors and pathways.

Authors:  Natalie A Sims; Nicole C Walsh
Journal:  Curr Osteoporos Rep       Date:  2012-06       Impact factor: 5.096

Review 6.  Eph- and ephrin-dependent mechanisms in tumor and stem cell dynamics.

Authors:  Erika Gucciardo; Nami Sugiyama; Kaisa Lehti
Journal:  Cell Mol Life Sci       Date:  2014-05-04       Impact factor: 9.261

Review 7.  Targeting the tumour vasculature: insights from physiological angiogenesis.

Authors:  Alicia S Chung; John Lee; Napoleone Ferrara
Journal:  Nat Rev Cancer       Date:  2010-07       Impact factor: 60.716

8.  Hemato-endothelial differentiation from lentiviral-transduced human embryonic stem cells retains durable reporter gene expression under the control of ubiquitin promoter.

Authors:  Hua Jiang; Xiaolong Lin; Youji Feng; Yi Xie; Jinlan Han; Yueping Zhang; Zack Z Wang; Tong Chen
Journal:  Cytotechnology       Date:  2010-03-18       Impact factor: 2.058

Review 9.  Differentiation and diversification of vascular cells from embryonic stem cells.

Authors:  Jun K Yamashita
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

10.  Differential variability analysis of gene expression and its application to human diseases.

Authors:  Joshua W K Ho; Maurizio Stefani; Cristobal G dos Remedios; Michael A Charleston
Journal:  Bioinformatics       Date:  2008-07-01       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.